Anthracycline derivatives having inhibitory activity against reverse transcriptase of human immunodeficiency virus
US5003055A · kind A · utility
1Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 23, 1988 |
| Grant date | Mar 26, 1991 |
| Priority date | — |
| Expiry date | Sep 23, 2008 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C65/21
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
As new compounds are now provided 14-O-(3,4-disubstituted benzoyl)adriamycins which are of low cytotoxicity and exhibit a high activity inhibitory to the reverse transcriptase of human immunodeficiency virus (HIV) and which can inhibit propagation of HIV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.